ANG Lifesciences India Limited (BOM:540694)

Market Cap	439.54M +15.8%
Revenue (ttm)	862.13M -24.3%
Net Income	-117.64M
EPS	-9.00
Shares Out	13.06M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,487
Open	33.66
Previous Close	33.66
Day's Range	32.66 - 34.87
52-Week Range	17.63 - 49.69
Beta	0.32
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About ANG Lifesciences India

ANG Lifesciences India Limited engages in manufacturing and sale of finished pharmaceutical formulations in India and internationally. Its product portfolio comprises therapeutics categories, such as antibiotics, antiviral, antimalarial, antiulcer, carbapenem, corticosteroid, penicillin, and beta lactamase inhibitor. The company offers its finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials, liquid injection vials, ampoules, PFS, hard gelatin capsules, soft gelatin capsules, dry syrups, liquid syrups and ...

• Industry: Pharmaceutical Preparations
• Founded: 2006
• Employees: 412
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 540694

Financial Performance

In fiscal year 2025, ANG Lifesciences India's revenue was 928.47 million, a decrease of -36.45% compared to the previous year's 1.46 billion. Losses were -124.13 million, 22.4% more than in 2024.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 8, 2026

Data Sources Report a data error